FLNA and rheumatoid arthritis: Pianta et al., using discovery-based proteomics to detect HLA-DR-presented peptides in synovia or peripheral blood mononuclear cells, identified N-acetylglucosamine-6-sulfatase (GNS) and filamin A (FLNA) as targets of T and B cell responses in 52% and 56% of RA patients, respectively.